The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant FOLFIRINOX and IMRT concurrent with FDR-gemcitabine in patients with borderline resectable pancreatic cancer (BRPC).
 
Nguyen H. Tran
No Relationships to Disclose
 
Vaibhav Sahai
Honoraria - Celgene; Halozyme; Merrimack
Consulting or Advisory Role - Celgene
Research Funding - Agios (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst)
 
Kent A. Griffith
No Relationships to Disclose
 
Hari Nathan
No Relationships to Disclose
 
Ravi Kaza
No Relationships to Disclose
 
Kyle Clifford Cuneo
No Relationships to Disclose
 
Christopher J Sonnenday
No Relationships to Disclose
 
Clifford Cho
No Relationships to Disclose
 
Theodore Steven Lawrence
No Relationships to Disclose
 
Mark Zalupski
Research Funding - Halozyme; Newlink Genetics/Pharmatech; Oncomed